GLOBAL MEDTECH COMPANY BRINGS DEVICE REPROCESSING PLANT TO AUSTRALIA Cardinal Health announces regional facility to support processing of hospital collected devices
With
Jane Crowe, Managing Director
Cardinal Health Australia and New Zealand &
Vice-Chair Medical Technology Association of Australia (MTAA)
Sabrina Lichtnegger, Lead Author
ECOFIDES Consulting GmbH, Vienna, Austria
Adam Walczak, Director of Innovation,
Hunter New England Local Health District
Ivan Waterfield, CEO
HunterNet
Australian Health Journal segment
Filmed in Sydney, Newcastle (NSW) and online | July 2024 to March 2025
It is estimated that healthcare contributes 1%–5% of the total global environmental footprint (source: The environmental footprint of health care: a global assessment, Lenzen, Manfred et al. The Lancet Planetary Health, Volume 4, Issue 7, e271 – e279)
And that Australia’s health system contributes 5.3% of the country’s greenhouse gas emissions via direct and indirect sources. Indirect sources include emissions generated in the manufacture of medical equipment and those generated from the incineration of waste. (Source: National Health and Climate Strategy, Commonwealth Government of Australia, Department of Health and Aged Care, 3 December 2023. ISBN: 978-1-74186-001-6)
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
Australian Health Journal spoke with Jane Crowe, Managing Director Cardinal Health Australia and New Zealand, about Cardinal Health’s reprocessing investment being a key part of Australia’s healthcare ESG efforts. Crowe talks about creating new jobs in Australia, as well as reducing medical waste and reducing landfill. Equally important, it will enhance Australia’s sovereign healthcare capability and boost supply chain resiliency for Cardinal Health’s customers.
Single-use device reprocessing is a well-established industry in the U.S., with growing global adoption. Single-use medical product reprocessing has the potential to extend the life of medical devices, and significantly reduce waste. This will enable health systems in Australia and New Zealand lower waste management costs while also supporting their sustainability goals.
In 2024, a peer-reviewed Life Cycle Assessment (LCA) study* conducted by a third-party engaged by Cardinal Health showed the overall environmental footprint of a reprocessed device was on average to be 43% lower than that of a single-use device. The assessment also showed that reprocessed compression sleeves had a 40% lower carbon footprint than single-use sleeves and reduced hospital compression sleeve waste disposal costs by 90%.
The facility will utilise a TGA-approved cleaning and disinfection process to remove soil, contamination and bio-burden from single-use medical devices. They then undergo functionality and quality testing, before being returned to hospitals for reuse, rather than contributing to landfill.
As noted by Invest Regional NSW, remanufacturing offers a significant opportunity to strengthen Australia’s health technology manufacturing capabilities. A well-established industry in the U.S., it has shown to substantially reduce the environmental impact of hospitals and medical device usage.
Source: Adapted from Cardinal Health supplied copy and March 2025 Invest Regional NSW Newsletter
-
Lived experience & human-centred design in healthcare
Recognised as one of the Top 100 Women of Influence by The Australian Financial Review, Melanie Tran is a visionary leader whose work lies at the intersection of design, technology, health, disability, and education. With a focus on human-centred design, digital strategy, and service design, she leads transformative initiatives as a Manager in Design, Digital and Data at Nous Group, a global consulting firm. Her work is driven by a deep passion for using creativity and technology to solve complex social challenges.
-
Landmark brain shape study
For over a century, researchers have thought that the patterns of brain activity that define our experiences, hopes and dreams are determined by how different brain regions communicate with each other through a complex web of trillions of cellular connections.
Now, a Monash University Turner Institute for Brain and Mental Health-led study has examined more than 10,000 different maps of human brain activity and found that the overall shape of a person’s brain exerts a far greater influence on how we think, feel and behave than its intricate neuronal connectivity.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
